Castle Free Cash Flow from 2010 to 2025
| CSTL Stock | USD 16.54 0.85 4.89% |
Free Cash Flow | First Reported 2018-03-31 | Previous Quarter 16.8 M | Current Value -10.8 M | Quarterly Volatility 11.2 M |
Check Castle Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Castle Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 3.5 M, Net Interest Income of 13 M or Interest Income of 13.6 M, as well as many indicators such as Price To Sales Ratio of 2.12, Dividend Yield of 0.0 or PTB Ratio of 1.71. Castle financial statements analysis is a perfect complement when working with Castle Biosciences Valuation or Volatility modules.
Castle | Free Cash Flow | Build AI portfolio with Castle Stock |
Latest Castle Biosciences' Free Cash Flow Growth Pattern
Below is the plot of the Free Cash Flow of Castle Biosciences over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Castle Biosciences' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Castle Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow | 10 Years Trend |
|
Free Cash Flow |
| Timeline |
Castle Free Cash Flow Regression Statistics
| Arithmetic Mean | (7,331,255) | |
| Geometric Mean | 15,151,890 | |
| Coefficient Of Variation | (285.59) | |
| Mean Deviation | 14,428,002 | |
| Median | (12,728,441) | |
| Standard Deviation | 20,937,549 | |
| Sample Variance | 438.4T | |
| Range | 85.7M | |
| R-Value | 0.37 | |
| Mean Square Error | 405.9T | |
| R-Squared | 0.14 | |
| Significance | 0.16 | |
| Slope | 1,620,317 | |
| Total Sum of Squares | 6575.7T |
Castle Free Cash Flow History
Other Fundumenentals of Castle Biosciences
Castle Biosciences Free Cash Flow component correlations
About Castle Biosciences Financial Statements
Castle Biosciences investors utilize fundamental indicators, such as Free Cash Flow, to predict how Castle Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow | 36.5 M | 38.4 M | |
| Free Cash Flow Yield | 0.05 | 0.05 | |
| Free Cash Flow Per Share | 1.32 | 1.38 | |
| EV To Free Cash Flow | 17.70 | 15.81 | |
| Price To Free Cash Flows Ratio | 20.26 | 26.37 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.56 | 0.98 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Castle Biosciences Correlation against competitors. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth 0.206 | Return On Assets |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.